Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide, Celecoxib, Etoposide, and Cyclophosphamide in Relapsed Malignant Glioma
NCT00047281Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Mar 2004
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thalidomide in malignant glioma, sponsored by Dana-Farber Cancer Institute. Started Mar 2004; status: completed.
02
Drugs
thalidomide
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT00047281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047281.